Volume 27, Number 12—December 2021
Dispatch
Rift Valley Fever Virus Seroprevalence among Humans, Northern KwaZulu-Natal Province, South Africa, 2018–2019
Janusz T. Pawęska
, Veerle Msimang, Joe Kgaladi, Orienka Hellferscee, Jacqueline Weyer, and Petrus Jansen van Vuren
, Veerle Msimang, Joe Kgaladi, Orienka Hellferscee, Jacqueline Weyer, and Petrus Jansen van Vuren
Table 2
Symptoms and signs in Rift Valley fever virus in IgM-positive participants by health care facility, uMkhanyakude district, northern Kwazulu-Natal, South Africa, 2018–2019*
| Healthcare facility | Age, y/sex | Fever | Rash | Headache | Myalgia | Arthralgia | Conjunctivitis | Vomiting | Malaria |
|---|---|---|---|---|---|---|---|---|---|
| Mbazwana |
30/M |
Y |
N |
Y |
N |
Y |
Y |
N |
Y |
| Ndumo-Mosvold | 55/F | N | N | Y | N | Y | N | N | N |
| 39/F | Y | Y | Y | Y | N | N | N | Y | |
| 50/F | N | N | N | N | N | N | N | NT | |
| 71/F | N | N | N | N | Y | N | N | NT | |
| 27/M | Y | N | Y | Y | N | N | N | NT | |
| 72/F | Y | N | Y | Y | Y | Y | N | NT | |
| 25/F |
N |
N |
Y |
Y |
Y |
N |
Y |
NT |
|
| Bethesda |
67/M |
Y |
N |
N |
Y |
N |
Y |
N |
NT |
| Manguzi-Mahlungulu |
15/F |
Y |
N |
N |
N |
Y |
N |
N |
NT |
| Mseleni | 47/F | N | N | Y | N | N | N | N | NT |
*NT, not tested.
Page created: October 06, 2021
Page updated: November 19, 2021
Page reviewed: November 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.